Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children

Alimentary Pharmacology and Therapeutics

Volumn 43, Issue 10, 2016, Pages 1025-1034

  Urbanska M ^a   Gieruszczak Bialek D ^a   Szajewska, H ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; HOSPITAL INFECTION; HUMAN; LACTOBACILLUS REUTERI; NONHUMAN; NOSOCOMIAL DIARRHEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; ROTAVIRUS DIARRHEA; ROTAVIRUS INFECTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; CHILD; CROSS INFECTION; HOSPITALIZED CHILD; META ANALYSIS; TIME FACTOR;

CHILD; CHILD, HOSPITALIZED; CROSS INFECTION; DIARRHEA; HUMANS; LACTOBACILLUS REUTERI; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS;

EID: 84962497252     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13590     Document Type: Review

References (33)

1. Guarino A, Ashkenazi S, Gendrel D, et al,. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014; 59: 132-52.
2. WHO Guidelines on Hand Hygiene In Health Care. First Global Patient Safety Challenge Clean Care is Safer Care. World Health Organization, 2009. Available at: http://whqlibdoc.who.int/publications/2009/9789241597906-eng.pdf (accessed 10 Dec 2015).
3. Karafillakis E, Hassounah S, Atchison C,. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine 2015; 33: 2097-107.
4. Mrukowicz J, Szajewska H, Vesikari T,. Options for the prevention of rotavirus disease other than vaccination. J Pediatr Gastroenterol Nutr 2008; 46 (Suppl 2): S32-7.
5. Hill C, Guarner F, Reid G, et al,. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11: 506-14.
6. Rosander A, Connolly E, Roos S,. Removal of antibiotic resistance plasmids from Lactobacillus reuteri ATCC 55 730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol 2008; 74: 6032-40.
7. Casas IA, Dobrogosz WJ,. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb Ecol Health Dis 2000; 12: 247-85.
8. Jones SE, Versalovic J,. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol 2009; 11 (9): 35.
9. Liu Y, Fatheree NY, Mangalat N, Rhoads JM,. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2010; 299: G1087-96.
10. Szajewska H, Urbańska M, Chmielewska A, Weizman Z, Shamir R,. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes 2014; 5: 285-93.
11. Higgins JPT, Green S, (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Avialable at: http://www.cochrane-handbook.org (accessed 12 Dec 2015).
12. Moher D, Liberati A, Tetzlaff J, Altman DG,; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
13. Guyatt GH, Oxman AD, Kunz R,. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64: 395-400.
14. Francavilla R, Lionetti E, Castellaneta S, et al,. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea-a double-blind study. Aliment Pharmacol Ther 2012; 36: 363-9.
15. Dinleyici EC,; PROBAGE Study Group, Vandenplas Y,. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr 2014; 103: e300-5.
16. Dinleyici EC, Dalgic N, Guven S, et al,. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr (Rio J) 2015; 91: 392-6.
17. Wanke M, Szajewska H,. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial. J Pediatr 2012; 161 (40-3): e1.
18. Urbańska M, Gieruszczak-Białek D, Szymański H, Szajewska H,. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: a Randomized, Double-blind, Placebo-controlled Trial. Pediatr Infect Dis J 2016; 35: 142-5.
19. Georgieva M, Pancheva R, Rasheva N, et al,. Use of the probiotic Lactobacillus reuteri DSM 17938 in the prevention of antibiotic associated infections in hospitalized bulgarian children: a randomized, controlled trial [In Process]. J IMAB-Annu Proc (Sci Pap) 2015; 21: 895-900.
20. Agustina R, Kok FJ, van de Rest O, et al,. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics 2012; 129: e1155-64.
21. Gutierrez-Castrellon P, Lopez-Velazquez G, Diaz-Garcia L, et al,. Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics 2014; 133: e904-9.
22. Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D,. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children-updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013; 38: 467-76.
23. Szajewska H, Skórka A,. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther 2009; 30: 960-1.
24. Cimperman L, Bayless G, Best K, et al,. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011; 45: 785-9.
25. Szajewska H, Kołodziej M,. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther 2015; 42: 1149-57.
26. Szajewska H, Kołodziej M,. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea. Aliment Pharmacol Ther 2015; 42: 793-801.
27. Szajewska H, Guarino A, Hojsak I, et al,. Use of probiotics for preventing antibiotic-associated diarrhoea. J Pediatr Gastroenterol Nutr 2016; 62: 495-506.
28. Szajewska H, Wanke M, Patro B,. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011; 34: 1079-87.
29. Wanke M, Szajewska H,. Probiotics for preventing healthcare-associated diarrhea in children: a meta-analysis of randomized controlled trials. Pediatr Pol 2014; 89: 8-16.
30. Hojsak I, Tokic Pivac V, Močic Pavic A, Kos T, Dumančic J, Kolaček S,. Bifidobacterium animalis subsp. lactis fails to prevent common infections in hospitalized children: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 2015; 101: 680-4.
31. Weizman Z, Asli G, Alsheikh A,. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005; 115: 5-9.
32. Hempel S, Newberry S, Ruelaz A, et al,. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep) 2011; 200: 1-645.
33. Generally Recognized as Safe (GRAS) Determination of Lactobacillus reuteri Strain DSM 17938 for Addition to Term Infant Formula. US Food and Drug Administration, 2011. Available at: www.fda.gov/downloads/food/ingredientspackaginglabeling/gras/noticeinventory/ucm287952.pdf (accessed 02 Jan 2016).